https://www.mdpi.com/1422-0067/23/14/7737
Despite initial responses to first-line treatment with platinum and taxane-based combination chemotherapy, most high-grade serous ovarian carcinoma (HGSOC)...
long noncoding rnaupregulationcisplatinresistance
https://pubmed.ncbi.nlm.nih.gov/24626000/
Cisplatin is a potent and a major anti-neoplastic drug in the treatment of a broad spectrum of malignancies. However, its clinical use is limited by renal...
protectiveeffectcisplatinnephrotoxicity
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1402514/full
Oral squamous cell carcinoma (OSCC) is a crucial public health problem, accounting for approximately 2% of all cancers globally and 90% of oral malignancies ...
as afrontierstargetingferroptosispotential
https://pubmed.ncbi.nlm.nih.gov/31791583/
Chemotherapy is an important method in the treatment of cervical cancer, but some patients will face drug resistance, which often indicates a poor prognosis....
hela cellsresistancecisplatinvia
https://www.chemoexperts.com/vip.html
Package insert & drug info about side effects by cancer pharmacists: videos & audio narration: VIP - Etoposide + Ifosfamide + Cisplatin | Testicular Cancer
vipetoposideifoscisplatintesticular
https://www.sigmaaldrich.com/US/en/tech-docs/paper/556017
Cisplatin-induced duplex dissociation of complementary and destabilized short GG-containing duplex RNAs. by Christopher Polonyi, Alak Alshiekh, Lamya A Sarsam,...
cisplatininducedduplexdissociationcomplementary
https://pubmed.ncbi.nlm.nih.gov/19178659/
Cisplatin is a platinum chemotherapeutic used in a variety of malignancies. The antineoplastic activity occurs from DNA cross-links and adducts, in addition to...
cisplatinreviewtoxicitiestherapeuticapplications
https://pubmed.ncbi.nlm.nih.gov/32978382/
Overtreatment with cisplatin-based chemotherapy is a major issue in the management of muscle-invasive bladder cancer (MIBC), and currently none of the reported...
molecularcisplatinbasedchemotherapyresponse
https://pubmed.ncbi.nlm.nih.gov/9197929/?dopt=Abstract
The effect of selenium (Se) in reducing the toxicity of cisplatin in cancer patients was studied. Forty-one patients were randomized into group A (20 patients...
protectiveroleseleniumtoxicitycisplatin
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.1124912/full
Cholangiocarcinoma (CCA) is a highly lethal gastrointestinal malignancy that has one of the worst prognoses among solid tumors. The combination of Gemcitabin...
smac mimeticfrontierscorrigendumcombininggemcitabine